Home
Directory
Destinations
Maps
Reports
Bookings
Español Español
  You are from:  Estados Unidos de America(select your country)
        My account   
Search
Questions?
+1 (833) 685-0373
Toll-Free

Bookings
Lodging
Cars
Flights
Envíos de Paquetería a Cuba
Directory
Accommodation
Top list
Attractions
Where to shop
Embassies
General information
Marinas
Where to dine
Health
Transportation
Nightlife
TOOLS
Distancies calculator
Travelers' Tips


We accept
We accept VISA and MasterCard credit cards.

Weekly report on Cuba's tourism industry
Search in DTCNews 
  ReportsAttractions |  Services |  Destinations |  Culture |  Health |  General
  NewsTourism |  Business |  Health |  Sports |  Culture
Heberprot-P Results Are Evaluated in Sancti Spiritus
Monday, December 2, 2019



Havana.- Experts from the central Cuban province of Sancti Spiritus are evaluating the results of the administration of the drug Heberprot-P.

The objective is to validate the aforementioned medication to treat diabetic foot ulcers, thus preventing amputations.

Experts from the Genetic Engineering and Biotechnology Center (CIGB) are conducting a clinical trial on patients who have been treated in the North and Center polyclinics in the provincial capital.

The research aims to demonstrate and provide evidence that the drug cures and is safe, as well as revealing that patients do not generate many antibodies against this drug.

The importance of such an exclusive study at this time in Cuba lies in the possibility of incorporating the drug into new markets in North America and Europe.



News
   HEADLINES

Home | Directory | Destinations | Reports | Flights | Lodging | Cars
About us | Terms and Conditions | Privacy Policy
(c) 1997-2025 Vacacionar Travel, SA. All rights reserved.